Radiography of rheumatoid arthritis in the time of increasing drug effectiveness
- 43 Downloads
Recent clinical development programs for new therapeutic agents in rheumatoid arthritis have included assessment of radiographic progression comparing changes with treatment to placebo and active controls. Studies now use reliable methods of assessment and sufficient study length to detect radiographic changes. Although patient populations and characteristics differ, and radiographic scoring methods vary, the direction of a series of studies appears to indicate that leflunomide (LEF), methotrexate (MTX), sulfasalazine (SSZ), etanercept, infliximab, and IL-1ra are all effective in retarding radiographic progression, as measured by erosions and joint space narrowing. Interpretation of radiograph data in future trials will be aided by utilization of common reading methods and by continuing comparison across differing rheumatoid arthritis protocol populations.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Sharp JT, Strand V, Leung H, Hurley F, LoewFriedrich I: Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 2000, 43:495–505. In three separate trials, leflunomide has been shown to significantly slow the progression of disease as measured radiographically. In addition, sulfasalazine and methotrexate are able to slow disease as measured radiographically.PubMedCrossRefGoogle Scholar
- 4.Rau R, Herborn G, Menninger H, Sangha O: Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998, 37:1220–1226. In patients with early erosive rheumatoid arthritis, methotrexate and gold salts were able to alter in a positive way the progression of the disease. Measures of inflammation (C-reactive protein and leptocyte sedimentation rate) and serum rheumatoid factor correlated with these changes.PubMedCrossRefGoogle Scholar
- 5.Boers M, Verhoeven AC, Markusse HM, et al.: Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997, 350:309–318. High doses of prednisolone were shown to have a significant clinical benefit in signs and symptoms and radiographic damage in patients with early rheumatoid arthritis.PubMedCrossRefGoogle Scholar
- 19.Sharp JT: Radiological assessment of joint damage—the premier outcome measure in rheumatoid arthritis—current status and future potential. In Wolfe F, Pincus T, editors. Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker, 1994:167–189.Google Scholar
- 24.WolfeF, Sharp JT: Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 1998, 41:1571–1582. A longitudinal study concluding that radiographic damage occurs at a constant rate in patients with rheumatoid arthritis and these changes correlate most strongly with acute phase reactants.PubMedCrossRefGoogle Scholar
- 26.Bland JM, Altman DG: Statistical methods for assessing agreement between to methods of clinical measurement. Lancet 1986, i:310.Google Scholar
- 27.Wolfe F, van der Heijde DM, Larsen A: Assessing radiographic status in rheumatoid arthritis: introduction of a shortened erosion scale. J Rheumatol. In press.Google Scholar
- 38.van der Heijde DMFM, van Riel PL, qvan Leeuwen MA, Van ’t Hof MA, van Rijswijk MH, van de Putte LBA: Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. Br J Rheumatol 1992, 31:519–525.PubMedCrossRefGoogle Scholar
- 40.Bathon JM, Martin RW, Fleischmann RM, et al.: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000, 343:1586–1593. Important study comparing etanercept and methotrexate in rheumatoid arthritis patients with early disease. Etanercept worked more quickly than methotrexate in decreasing symptoms and slowing joint damage.PubMedCrossRefGoogle Scholar
- 41.Lipsky PE, van der Heijde DMFM, St. Clair EW, et al.: Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000, 343:1594–1602. Very important study demonstrating the combination of infliximab and methotrexate significantly decreased symptoms and radiographic progression of disease in rheumatoid arthritis patients with persistent disease despite treatment with methotrexate.PubMedCrossRefGoogle Scholar